The role of angiogenesis in prostate and other urologic cancers: a review

Izawa, Jonathan I.; Dinney, Colin P.N.
March 2001
CMAJ: Canadian Medical Association Journal;3/06/2001, Vol. 164 Issue 5, p662
Academic Journal
Angiogenesis is a process critical to both tumour growth and metastasis. It is a dynamic integrated process involving basement membrane degradation, endothelial cell proliferation and migration, and capillary tubule formation. Under normal circumstances, the microvasculature is maintained in a quiescent state. The acquisition of the angiogenic phenotype depends on the outcome of stimulatory and inhibitory regulation by the tumour and its microenvironment. There are markers of angiogenesis that potentially could provide prognostic information in addition to that gained from conventional clinicopathologic data, and antiangiogenic therapy for urologic cancers has potential advantages over current therapeutic strategies. Promising preclinical studies have led to the initiation of phase I studies of antiangiogenic therapy in combination with chemotherapy, which may lead to novel treatments for urologic malignant tumours and may identify new intermediate markers for the response to therapy.


Related Articles

  • Herceptin acts as an anti-angiogenic cocktail. Izumi, Yotaro; Lei Xu; di Tomaso, Emmanuelle; Fukumura, Dai; Jain, Rakesh K. // Nature;3/21/2002, Vol. 416 Issue 6878, p279 

    Examines the role of angiogenesis inhibitors on tumors growth. Indication of monoclonal antibody on human epidermal growth factor receptor; Regression of the vasculature; Normalization of host stromal cell.

  • HIF-1 gene identified as prostate cancer promoter. Carlson, Robert // Urology Times;May2000, Vol. 28 Issue 5, p28 

    Reports that researchers from the Johns Hopkins University have identified a new candidate for cancer treatment, the hypoxia-inducible factor 1 alpha (HIF-1) gene, including inhibition of potentially angiogenic tumors. Abnormal activation of the HIF-1 in prostate and other cancer cells;...

  • Low plasma levels of matrix metalloproteinase 9 permit increased tumor angiogenesis. Pozzi, Ambra; LeVine, Wendy F.; Gardner, Humphrey A. // Oncogene;1/10/2002, Vol. 21 Issue 2, p272 

    Deals with a study which tested doxycycline as an inhibitor of matrix metalloprotein (MMP) 9 to control tumor angiogenesis. Information on MMP; Methodology of the study; Results and discussion.

  • Switch control. Novak, Kristine // Nature Reviews Drug Discovery;Jun2003, Vol. 2 Issue 6, p420 

    Focuses on the use of an angiogenic switch in detecting various stages of tumorigenesis in transgenic mice. Stage at which such a switch is formed; Efficacy of anti-tumor angiogenesis therapy using soluble receptors RIP1 TAG2; Importance of vascular endothelial growth factor in angiogenic...

  • Pomegranate Inhibits Prostate Cancer: New Evidence. Kiefer, Dale // Life Extension;Jun2008, Vol. 14 Issue 6, p24 

    The article reports on a study analyzing the therapeutic claims of pomegranate in prostate cancer. New research reveals that pomegranate may help fight prostate cancer through inhibiting angiogenesis, the process whereby tumors grow new blood vessels to support their growth. When mice that had...

  • Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment. Li, Xin; Li, Yang; Wang, Bo; Ji, Kun; Liang, Zuowen; Guo, Baofeng; Hu, Jiadi; Yin, Di; Du, Yanwei; Kopecko, Dennis; Kalvakolanu, Dhananjaya; Zhao, Xuejian; Xu, Deqi; Zhang, Ling // Journal of Cancer Research & Clinical Oncology;Jun2013, Vol. 139 Issue 6, p971 

    Objectives: To investigate the therapeutic utility of an attenuated bacterium carrying a plasmid that co-expresses Endostatin, an inhibitor of tumor neovasculogenesis, and a shRNA that targets Stat3 to suppress prostate cancer growth. Methods: Plasmid pEndo-Si-Stat3 was constructed and...

  • RNAi Silences Tumor Factor. Tolchin, Elizabeth // Genomics & Proteomics;Nov/Dec2004, Vol. 4 Issue 9, p11 

    This article focuses on the significance of a protein in tumor angiogenesis. To find out the role of protein in tumor growth, researchers used RNA interference to down-regulate its expression in mice. The protein of interest, sphingosine 1-phosphate receptor 1 (S1P1), was originally isolated...

  • Angiogenic Inhibitors: Role In The Cancer Treatment. Desai, Devenkumar V.; Bindi, Shukla; Kapoor, Amit; Yeluri, Sashidhar; Saxena, Mohit // Internet Journal of Oncology;2004, Vol. 2 Issue 1, p1 

    Angiogenesis is one of the basic important mechanisms for the tumor growth. Tumor cells produce these angiogenic molecules along with the antiangiogenic molecules as well. If exogenous introduction of the antiangiogenic substances, to the body, is done to balance over angiogenic molecules, tumor...

  • Fibroblast Growth Factors, Fibroblast Growth Factor Receptors, Diseases, and Drugs. Chen, Gregory J.; Forough, Reza // Recent Patents on Cardiovascular Drug Discovery;Jun2007, Vol. 2 Issue 2, p211 

    Maintenance of endothelial cells (ECs), the building blocks of the vascular tree, is a presumed function of fibroblast growth factors (FGFs). In particular, the two prototypic members of FGF family, namely FGF1 and FGF2, due to their potent mitogenic and pro-migratory activities, have the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics